About Siponimod
            
            Class: | Sphingosine 1-phosphate receptor modulator  
Use: | Treatment of relapsing forms of multiple sclerosis (MS) in adults  
Adult dose: | Initial dose: 0.25 mg once daily after a 0.25 mg loading dose on the first day; maintenance dose: 0.25 mg once daily  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Headache, hypertension, liver enzyme elevation, bradycardia, infections, macular edema  
Contraindications: | Hypersensitivity to siponimod or a
         
        
            
                
                
                    
                        Drug Class
                    
                    Sphingosine 1-phosphate receptor modulator
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of relapsing forms of multiple sclerosis (MS) in adults
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Novartis Pharmaceuticals Corporation, U.S.A
                    
                    
                    Package Size
                    12s
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 990.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose: 0.25 mg once daily after a 0.25 mg loading dose on the first day; maintenance dose: 0.25 mg once daily
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Headache, hypertension, liver enzyme elevation, bradycardia, infections, macular edema
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to siponimod or any component of the formulation; active infections; severe hepatic impairment; concurrent use of strong CYP2C9 inhibitors
         
        
        
            
                Important Warnings
            
            Risk of serious infections, including progressive multifocal leukoencephalopathy (PML); monitor liver function; may cause bradycardia; contraindicated in patients with a history of certain cardiac conditions; requires monitoring of blood pressure and heart rate during treatment initiation.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.